摘要 一系列新的 4-methyl-2-{2-[(aryl)methylidene]hydrazinyl}-1,3-thiazole (2a-i) , N -(4-acetyl-5-aryl)4,5-dihydro- 1,3,4-噻二唑-2-基)乙酰胺(3a-b)和N -(5-(4-(取代苯基)-1,3,4-噻二唑-2-基)乙酰胺(3c-i)由 2-((aryl)methylene)hydrazine-1-carbothioamides (1a-i)和乙酸酐或氯丙酮反应合成。产物的细胞毒活性通过 MTT(3-(4,5-二甲基噻唑 - 2-yl)-2,5-diphenyltetrazolium bromide) assay against Hela cervical cancer, MCF-7 breast carcinoma and HT-29 colorectal cancer lines